Kenneth Felsenstein

Title: Kenneth Felsenstein: Innovator in Cancer Treatment

Introduction

Kenneth Felsenstein is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 3 patents, Felsenstein's work focuses on developing methods to treat tumors effectively.

Latest Patents

Felsenstein's latest patents include groundbreaking methods for treating both benign and malignant tumors. His patent titled "MYC G-quadruplex stabilizing small molecules and their use" discloses methods that involve administering a therapeutically effective amount of a small molecule. This molecule selectively binds to and stabilizes G-quadruplex DNA in the promoter of the c-MYC gene. The methods aim to decrease the size and/or number of metastases, providing a promising avenue for cancer treatment.

Career Highlights

Throughout his career, Kenneth Felsenstein has worked with esteemed organizations, including the United States Department of Health and Human Services and Yale University. His research has been pivotal in advancing the understanding of cancer biology and treatment methodologies.

Collaborations

Felsenstein has collaborated with notable colleagues such as Lindsey Saunders and John Schneekloth, Jr. These partnerships have further enriched his research and contributed to the success of his inventions.

Conclusion

Kenneth Felsenstein's innovative work in cancer treatment exemplifies the impact of dedicated research and invention in the medical field. His contributions continue to pave the way for advancements in therapeutic methods for tumors.